Rocket Pharmaceuticals Inc (NASDAQ:RCKT)
| 18.85 Delayed Data As of 3:59pm ET |  -0.60 / -3.08%Today’s Change | 14.86 Today|||52-Week Range 24.65 | -3.68% Year-to-Date |
Latest RCKT News | Press Releases
| Better Gene Editing Stock: Intellia Therapeutics vs. Rocket Pharmaceuticals Sep 23 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 19.45 |
| Today’s open | 19.19 |
| Day’s range | 18.81 - 19.58 |
| Volume | 66,753 |
| Average volume (3 months) | 1,038,635 |
| Market cap | $1.8B |
Data as of 3:59pm ET, 10/03/2023
Growth & Valuation
| Earnings growth (last year) | -21.77% |
| Earnings growth (this year) | +4.50% |
| Earnings growth (next 5 years) | +30.28% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.31 |
Competitors
Data as of 4:00pm ET, 10/03/2023
Financials
| Next reporting date | November 8, 2023 |
| EPS forecast (this quarter) | -$0.80 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$221.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cranbury, New Jersey |
Forecasts
